Filter
50
Filtered Results: 50
Text search:
R.
Barnabas
Featured
Recommendations
7
New Publications
21
Language
Document type
Guidelines
25
Studies & Reports
12
No document type
10
Manuals
3
Countries / Regions
Burkina Faso
2
Global
2
South Africa
2
Kenya
1
Lesotho
1
Malawi
1
Mozambique
1
Africa
1
Latin America and the Carribbean
1
Tanzania
1
Brazil
1
Russia
1
Namibia
1
Ethiopia
1
Angola
1
Authors & Publishers
Publication Years
Category
Studies & Reports
5
COVID-19
3
Virology
3
Policies & Guidelines HIV & TB
2
Communicable Diseases
1
Monitoring & Evaluation
1
NCD
1
Demograhic Health Surveys DHS
1
Policies
1
Guidelines
1
Drugs & Medical Equipment
1
Community Health
1
Capacity Building
1
Statistics
1
Respiratory Infections
1
Health Systems
1
Toolboxes
Diagnostics & Laboratory Guidance
15
Genomic sequencing
6
Surveillance & Contact tracing
5
HIV testing & services
4
Laboratory Guidance
3
Clinical Guidelines
3
Children & Adolescents
2
Public Health
2
Studies & Reports
2
Reports & Studies
2
Eastern and Southern Africa
2
Agriculture & Veterinary
1
Clinical Aspects
1
Global
1
Discrimination & Stigma
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Public Health
1
Training, others
1
Country specific documents
1
Common Good
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Hospital Readiness/Essential Health Services
1
Nurses
1
Planetary Health
1
Agriculture
1
Women
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Reports & Studies Children HIV
1
Journal of the International AIDS Society, vol. 21 Issue no. 6 e 25142
Weaknesses in care programmes providing anti‐retroviral therapy (ART) persist and are often instigated by late HIV diagnosis and poor linkage to care. We investigated the potential for a home‐based counselling and testin...
Weaknesses in care programmes providing anti‐retroviral therapy (ART) persist and are often instigated by late HIV diagnosis and poor linkage to care. We investigated the potential for a home‐based counselling and testin...
2006-2008 programme report
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic...
Choko AT et al. Journal of the International AIDS Society 2017, 20:21610 http://www.jiasociety.org/index.php/jias/article/view/21610 | http://dx.doi.org/10.7448/IAS.20.1.21610
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Previous studies have highlighted a range of individual determinants associated with HIV testing but few have assessed the role of contextual factors. The objective of this paper is to examine the influence of both individual and community-level determinants of HIV testing uptake in Burkina Faso.
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
Este documento apresenta uma orientação provisória aos laboratórios e diferentes atores envolvidos na realização de exames laboratoriais para o vírus COVID-19. Ele baseia-se parcialmente na orientação provisória para os exames laboratoriais do coronavírus da Síndrome Respiratória do Ori...
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
To evaluate the epidemiological evolution of patients with HIV (PtHIV), between 2002 and 2012, in a day-hospital that became an HIV reference centre for south-west Burkina Faso.
This was a retrospective study of PtHIV followed in the Bobo Dioulasso university hospital since 2002. The study was ba...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
Updated Treatment Guidelines
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
